Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2016: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2015: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
Outline of Final Research Achievements |
We assessed liver stiffness (LS) using magnetic resonance elastography before and after direct acting antivirals (DAAs)-based therapy in 52 patients with chronic hepatitis C. The median LS measurement (LSM) significantly decreased at end of treatment (3.01 kPa) and 6 months after end of treatment (2.59 kPa) compared with baseline (3.69 kPa)(p<0.001). However, we discovered some cases that the LSM turned worse. In the future, a large-scale and long-term analysis of patients with smaller improvements in LSM could enable patients with a high risk of carcinogenesis after HCV elimination to be identified.
|